Product Pathways - Protein Translation
IRE1α (14C10) Rabbit mAb #3294
|3294S||100 µl (10 western blots)||---||In Stock||---|
|3294P||40 µl (4 western blots)||---||In Stock||---|
|3294||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse||Endogenous||130||Rabbit IgG|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Specificity / Sensitivity
IRE1α (14C10) Rabbit mAb detects endogenous levels of total IRE1α protein.
Source / Purification
IRE1α (14C10) Rabbit mAb is produced by immunizing rabbits with a synthetic peptide corresponding to residues surrounding His963 of human IRE1α.
The secretory, intra-organellar and transmembrane proteins translocate into the endoplasmic reticulum (ER) after their synthesis. Inside the ER, they are post-translationally modified and properly folded. Disruptions of ER homeostasis leads to the accumulation of unfolded proteins (1). The ER has developed an adaptive mechanism called unfolded protein response (UPR) to counteract compromised protein folding (1). One of the players in UPR, IRE1, was first identified in Saccharomyces cerevisiae as a transmembrane serine/threonine kinase (2-4). This kinase was proposed to be a proximal sensor for UPR that transmits the unfolded protein signal across the ER membrane (3,4). A human homolog of this kinase, IRE1α, was later identified and shown to be ubiquitously expressed in human tissues (5). Upon activation of UPR, IRE1α splices X-box binding protein (XBP1) mRNA by an unconventional mechanism using its endoribonuclease activity (6). This converts XBP1 into a potent transcriptional activator that induces many UPR responsive genes (6). Recently, IRE1α was shown to mediate the rapid degradation of certain mRNAs based on the ER-localization and primary sequences of their encoded proteins, suggesting a novel mechanism in UPR (7).
- Kaufman, R.J. et al. (2002) Nat Rev Mol Cell Biol 3, 411-421.
- Nikawa, J. and Yamashita, S. (1992) Mol. Microbiol. 6, 1441-1446.
- Cox, J.S. et al. (1993) Cell 73, 1197-1206.
- Mori, K. et al. (1993) Cell 74, 743-756.
- Tirasophon, W. et al. (1998) Genes Dev. 12, 1812-1824.
- Lee, K. et al. (2002) Genes Dev. 16, 452-466.
- Hollien, J. and Weissman, J.S. (2006) Science 313, 104-107.
- De Raedt, T. et al. (2011) Cancer Cell 20, 400-13. Applications: Western Blotting.
- Osorio, F. et al. (2014) Nat Immunol , . Applications: Western Blotting.
- Chen, X. et al. (2014) Nature 508, 103-7. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
U.S. Patent No. 5,675,063.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.